SFX by Ex Libris Inc.

Title:	Mutations in NEK8 link multiple organ dysplasia with altered Hippo signalling and increased c-MYC expression
Source:	Human Molecular Genetics [0964-6906] Frank, V yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gao, T. "Hippo Signaling Regulates Differentiation and Maintenance in the Exocrine Pancreas." Gastroenterology 144.7 (2013): 1543-53.
description	2.	Nallet Staub, F. "Characterization of the Hippo Pathway in Melanoma: Focus on the effectors YAP and TAZ." Journal of investigative dermatology 2012.
description	3.	Lavado, A. "The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap." Development 141.21 (2014): 4182-93.
description	4.	Yu, F. "The Hippo pathway: regulators and regulations." Genes & development 27.4 (2013): 355-371.
description	5.	Day, Nora E. "Hippo signaling regulates pancreas development through inactivation of Yap." Molecular and cellular biology 32.24 (2012): 5116-28.
description	6.	Cordenonsi, M. "The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells." Cell 147.4 (2011): 759-772.
description	7.	Brummelkamp, Thijn R R. "YAP1 increases organ size and expands undifferentiated progenitor cells." Current biology 17.23 (2008): 2054-60.
description	8.	Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q.,, B. "Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control." Genes & development 21.21: 2747-2761.
description	9.	Tumaneng, K. "Organ Size Control by Hippo and TOR Pathways." Current biology 22.9 (2012): -79.
description	10.	Badouel, C. "SnapShot: The Hippo Signaling Pathway." Cell 145.3 (2011): 484-4840.
description	11.	Pan, D. "The hippo signaling pathway in development and cancer." Developmental cell 19.4 (2010): 491-505.
description	12.	Pece, S. "Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content." Cell 140.1 (2010): 62-73.
description	13.	Stehling-Sun, S.. "Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c." Nature immunology 10.3 (2009): 289-96.
description	14.	Enneking, E. "Transsynaptic Coordination of Synaptic Growth, Function, and Stability by the L1-Type CAM Neuroglian." PLoS Biology 11.4 (2013).
description	15.	Jakab, A. "Disrupted developmental organization of the structural connectome in fetuses with corpus callosum agenesis." NeuroImage 111.C (2015): 277-288.
description	16.	Tsuneki, M. "Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior." Molecular and cellular biology 34.24 (2014): 4485-99.
description	17.	Kopp, Janel L. "Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma." Cancer cell 22.6 (2012): 737-750.
description	18.	Heallen T, T. "Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size." Science 332.6028 (2011): 458-461.
description	19.	Castillo, Alesha B. "Mesenchymal stem cell mechanobiology." Current Osteoporosis Reports 8.2 (2010): 98-104.
description	20.	Zhan, L. "Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma." Cell 135.5 (2008): 865-878.